SEC Form D · Amendment · filed September 3, 2009
IRONWOOD PHARMACEUTICALS INC
People & firms on this filing (24)
Christopher T. Walsh · CAMBRIDGE, MADirectorJeffrey Meyer · London, United KingdomDirectorStephen Knight · CAMBRIDGE, MADirectorDr. Paul Bolster · Andover, MAExec · DirectorRoger Guy · London EC3M 4PB, United KingdomDirectorDavid Shaw · CAMBRIDGE, MADirectorKenneth Lubbock · New York, NYExecMichael J. Higgins · CAMBRIDGE, MAExecGeorge H. Conrades · CAMBRIDGE, MADirectorRobert Bovert · Vaud, V8DirectorHugh Ward · Jersey, United KingdomExecGina B. Miller · CAMBRIDGE, MADirectorLes Aitkenhead · London, United KingdomDirectorNeil Honebon · London, United KingdomDirectorTerrance G. Mcguire · CAMBRIDGE, MADirectorKenneth Lubbock · New York, NYDirectorMark G. Currie · CAMBRIDGE, MAExecJoseph C. Cook, Jr · CAMBRIDGE, MADirectorBryan E. Roberts · CAMBRIDGE, MADirectorPaul Bolster · Andover, MADirectorRobert Bovet · Vaud, V8DirectorPeter M. Hecht · CAMBRIDGE, MAExec · DirectorDavid Ebersman · CAMBRIDGE, MADirectorStuart Leckie · Queensway, Hong KongDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗